These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18829503)

  • 1. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
    J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
    Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
    Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
    Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.
    Garcia J; Faca V; Jarzembowski J; Zhang Q; Park J; Hanash S
    J Proteome Res; 2009 Aug; 8(8):3791-6. PubMed ID: 19505085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.
    Sandoval JA; Eppstein AC; Hoelz DJ; Klein PJ; Linebarger JH; Turner KE; Rescorla FJ; Hickey RJ; Malkas LH; Schmidt CM
    J Surg Res; 2006 Jul; 134(1):61-7. PubMed ID: 16650873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.
    Geerts D; Wallick CJ; Koomoa DL; Koster J; Versteeg R; Go RC; Bachmann AS
    Clin Cancer Res; 2007 Nov; 13(21):6312-9. PubMed ID: 17975142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
    Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel peptides secreted from human neuroblastoma: useful clinical tools?
    Sandoval JA; Hoelz DJ; Woodruff HA; Powell RL; Jay CL; Grosfeld JL; Hickeyd RJ; Malkas LH
    J Pediatr Surg; 2006 Jan; 41(1):245-51. PubMed ID: 16410142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach.
    Otake K; Uchida K; Ide S; Kobayashi Y; Kobayashi I; Kusunoki M
    Pediatr Blood Cancer; 2016 Feb; 63(2):221-7. PubMed ID: 26469522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?
    Sandoval JA; Dobrolecki LE; Huang J; Grosfeld JL; Hickey RJ; Malkas LH
    J Pediatr Surg; 2006 Apr; 41(4):639-46; discussion 639-46. PubMed ID: 16567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
    Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
    Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
    Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
    Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.